alnylam is across the street from genzyme. and this model gives us access to a portfolio of new treatments for rare diseases. but it's also, i think, different model in the sense that you know, alnylam also announced an acquisition of patents from a company called cerna that merck acquired. the technology always hasn't done that well. so this is an opportunity for us to participate as a partner, shareholder, but to also leave alnylam not only as an autonomous company but grow from being research and development company to fully-fledged, integrated commercial company. that's the logic behind that. >> is that a new strategy in the sense of, many offo our viewers recall the large acquisition of genzyme. are those deals not going to happen in the future, as opposed to replaced with the like of this transaction or your ownership in regeneron, for example. >> it was the model for this transaction. soed, sano today, sanofi has one of the top five pipelines in the industry today. a large coming from regenero. there's a positive relati

. >> right before jpmorgan announced a transformational deal, genzyme acquired 10% of our companies -- our company which takes us to the next level. what that allows us to do is translate a series of products to now become commercial in this regional deal. it alleviates the need to tap the equity markets and prosecuted rod pipeline of therapeutics. this is something we articulated clearly -- we are going after the genetic cause of the disease. diseases cause often by too much or too little protein. we are targeting genes with a genetic cause of the disease. in phase one, if we knock down the disease causing gene, we have a high probability of clinical but if it. >> will you spend more time with us in the future? >> i would love to. >> alan meckler from --alnylam pharmaceuticals, inc. you very much. this is "taking stock" on bloomberg. ♪ >> this is "taking stock" on bloomberg. i'm pimm fox. microsoft is preparing to make such an adele -- the board is also discussing replacing bill gates as chairman. gates addressed his role at microsoft last week when he sat down with bloomberg's betty

over the world and in countries that we may not have gotten to as quickly as we will now with the genzymen: i know that you are in san francisco right now, but you live outside of boston? >> in the heart of mit at cambridge. dagen: so, go patriots is how we should in this? $700 million. connell: we have this time warner cable story. we have time warner cable to get to. ♪ [ male announcer ] what if a small company became big business overnight? ♪ like, really big... then expanded? ♪ or their new product tanked? ♪ or not? what if they embrace new technology instead? ♪ imagine a company's future with the future of trading. compy profile. a research tool on thinkorswim. from td ameritrade. open to innovation. open to ambition. open to boldids. that's why n yor has a new plan -- dozens of tax free zones all across the state. move here, expand here, or start a new business here and pay no taxes for ten years... we're new york. if there's mething that creates more jobs, and ows more businesses... we're open to it. start a tax-frebusiness at startup-ny.com. connell: time warner cable has reject a